Primary biliary cirrhosis after benoxaprofen
Benoxaprofen was withdrawn from use in 1982 because of reports of it causing fatal, cholestatic jaundice. We report three cases of primary biliary cirrhosis after benoxaprofen, an association not previously recognised.
Case reports CASE 1 A 67 year old woman received benoxaprofen 600 mg/day for three months in 1981 for sciatica. A further course was given between April and June 1982, during which she developed a photosensitive rash and brittle nails. Shortly afterwards she was found to have raised serum alkaline phosphatase activity. From November 1982 she noticed increasing skin pigmentation, followed eight months later by jaundice and hepatomegaly. Follow up confirmed persistently abnormal liver function with a positive result on antimitochondrial antibody testing and liver histology compatible with primary biliary cirrhosis (table). CASE 2 A 57 year old woman with rheumatoid arthritis received benoxaprofen 600 mg/day from December 1980 to June 1982, when she developed a generalised, pruritic rash that cleared when the drug was stopped, although pruritus persisted. In March 1983 she was admitted to hospital with deep jaundice, loss of weight and hepatosplenomegaly. The results of an antimitochondrial antibody test were positive; liver function deteriorated until her death 28 months after initial diagnosis.
CASE 3
A 62 year old woman with primary hyperparathyroidism was admitted to hospital in January 1983 with lethargy, nausea, and vomiting. She had received benoxaprofen 600 mg/day from April 1981 to March 1982, when she developed a pruritic rash; two months before this her liver function tests had yielded normal results. FoLlow up over 30 months confirmed persistently raised serum alkaline phosphatase activity despite normal concentrations ofserum calcium and positive results on antimitochondrial antibody testing.
Comment
The cause of primary biliary cirrhosis remains unknown, but knowledge about the clinical course of the disease has changed in recent years with increasing awareness ofa long presymptomatic phase. The factors leading to hepatic decompensation and presentation with symptoms are obscure, though several drugs, including arsenicals, chlorpromazine, methyltestosterone, and tolbutamide have been implicated.' Some reported cases had a history different from that of classic primary biliary cirrhosis, with a more rapid onset and complete or partial resolution after stopping the drug. Other patients, however, have developed progressive liver damage and portal hypertension.' In the early reports the antimitochondrial antibody test was not available, but more recently cases ofprimary biliary cirrhosis associated with drugs have been reported as positive for antimitochondrial antibody.23 Our first two patients had classic primary biliary cirrhosis with the specific anti-M2 antimitochondrial antibody subtype present in serum. The third patient almost certainly had primary biliary cirrhosis despite the absence of histological confirmation.
Cholestatic jaundice is a well recognised complication of benoxaprofen treatment,4 and, although the mechanism is unknown, it is probably related to high concentrations of benoxaprofen accumulating in elderly patients with impaired renal function. Renal function was normal in our patients, suggesting that a different mechanism may have been responsible for the development of primary biliary cirrhosis. Recently, drug metabolism has been shown to be abnormal inprimary biliary cirrhosis, with 95% ofpatients exhibiting impaired sulphoxidation, and in the cases tested (l and 2) this was clearly shown ( responses. Blood glucose concentration was 1-0 mmol/l (18 mg/I00 ml) and she rapidly regained consciousness after receiving an infusion of 50%/o glucose. On recovery she was found to be mute, withdrawn, and profoundly deaf, requiring considerable nursing care. She had a spastic gait but no evidence of peripheral neuropathy. A full history was obtained from her father, who described her physical and intellectual development during childhood as normal: at 16 she could competently read and write and on leaving school she worked for a local pharmaceutical firm. Since then her intellect, personality, hearing, and speech had gradually deteriorated. On neurological assessment in 1973 she was found to be deaf, uncommunicative, and mentally retarded with mild right sided pyramidal signs; no diagnosis was established. In 1976 she could no longer be managed at home and entered the hostel. Thereafter she had increasingly frequent episodes of transient neurological disturbance: inappropriate affect, confusion, ataxia, dense right hemiparesis, opisthotonoid seizures, and unconsciousness were all noted at different times and attributed to a combination of transient ischaemic attacks, epilepsy, and anticonvulsant toxicity. These episodes tended to occur in the early morning and invariably resolved within a few hours. They were superimposed
